
Evoke Pharma Inc Investor Relations Material
Latest events

Q4 2024
Evoke Pharma Inc
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Evoke Pharma Inc
Access all reports
Evoke Pharma Inc. is a specialty pharmaceutical company focused on the development and commercialization of treatments for gastrointestinal (GI) disorders. The company’s primary focus is on addressing unmet medical needs related to conditions that affect GI motility. Evoke Pharma's products are designed to offer novel delivery methods to improve patient outcomes, particularly for those with chronic and debilitating GI issues. The company's approach involves enhancing therapeutic efficacy and patient convenience through innovative formulations. The company is headquartered in Solana Beach, California, and its shares are listed on the NASDAQ.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
EVOK
Country
🇺🇸 United States